Orchestra BioMed Holdings, Inc. Debt Conversion, Converted Instrument, Amount
Orchestra BioMed Holdings, Inc. (OBIO) reported Debt Conversion, Converted Instrument, Amount of $66.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2024-03-27
- Orchestra BioMed Holdings, Inc. debt conversion, converted instrument, amount for the quarter ending 2022-12-31 was $0.00.
- Orchestra BioMed Holdings, Inc. debt conversion, converted instrument, amount for the quarter ending 2022-09-30 was $0.00.
- Orchestra BioMed Holdings, Inc. debt conversion, converted instrument, amount for fiscal 2023 was $66.00K, a 62.92% decline from fiscal 2022.
- Orchestra BioMed Holdings, Inc. debt conversion, converted instrument, amount for fiscal 2022 was $178.00K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2023-12-31 | $66.00K 10-K · filed 2024-03-27 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $0.00 derived: sum of 2 quarters · filed 2024-03-27 | $178.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $178.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $178.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |